IP Library Granted Patent US 8,119,398
Granted Patent B2
US 8,119,398 · App. 11/323,276 · Granted Feb 21, 2012

Adipose-derived stem cells for tissue regeneration and wound healing

Assignee: PrimeGen Biotech LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,119,398
App. No.
11/323,276
Granted
Feb 21, 2012
Kind
B2
Abstract

Compositions and methods for promoting tissue regeneration, particularly skin regeneration, with adipose-derived stem cells are provided. Additionally methods and compositions for promoting tissue regeneration with adipose-derived stem cell side population cells are provided. The adipose-derived cells are administered in a tissue regenerating effect amount optionally with a bioactive agent. Additionally the adipose derived cells can be autologous or syngeneic.

Claims (5)

1. A therapeutic composition for promoting tissue regeneration in a mammal comprising isolated adipose-derived stem cell side population (ADSC-SP) cells, wherein said side population consists essentially of cells having the phenotype Lin − , Sca-1 + , CD90 + , CD34 low , CD13 low , CD117 − and CD18 low .

2. The therapeutic composition of claim 1 further comprising a pharmaceutically acceptable carrier.

3. The therapeutic composition of claim 1 wherein said mammal is a human.

4. An isolated mammalian adipose derived stem cell side population (ADSC-SP) wherein said isolated ADSC-SP cells comprise a subpopulation isolated from adipose-derived stem cell main population cells, and said isolated ADSC-SP cells consist essentially of cells having the phenotype Lin − , Sca-1 + , CD90 + , CD34 low , CD13 low , CD117 − and CD18 low .

5. The isolated mammalian ADSC-SP of claim 4 wherein said mammal is a human.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2006
From: SAYRE, CHAUNCEY BIGELOW; SILVA, FRANCISCO J.
To: PRIMEGEN BIOTECH LCC
Reel/Frame 017219/0846 →
Continuity (2)
Provisional Application 60641034 · Dec 30, 2004
Related Publication 20060147430A1 · Jul 6, 2006